Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
cancer
crispr
5
×
deals
5
×
life sciences
national
5
×
national blog main
national top stories
novartis
boston blog main
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biogen
boston top stories
cancer immunotherapy
clinical trials
editas medicine
gene therapy
ipo
pfizer
startups
abbvie
What
bio
roundup
car
gene
life
millions
new
science
talk
therapy
access
acquisitions
advanced
announced
approval
bails
becker
billions
biogen’s
biopharmaceutical
brand
bridgebio
capacity
capital
cell
ceo
collabs
companies
consolidation
convo
covid
crispr
daniel
deal
develop
dollars
drug
drugs
earlier
eaton
Language
unset
Current search:
crispr
×
deals
×
national
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More